Zobrazeno 1 - 9
of 9
pro vyhledávání: '"AZM, Azithromycin"'
Autor:
Evdoxia J Apostolopoulos, Helen Melita, Antonis A. Manolis, Antonis S. Manolis, Theodora A Manolis, Despoina Papatheou
Publikováno v:
Trends in Cardiovascular Medicine
Highlights • Serious cardiac arrhythmias may be the consequence of direct effects of COVID-19 infection, but also the outcome of the deleterious effects of systemic illness and the adverse proarrhythmic reactions to drugs employed in the treatment
Autor:
Koichi Yamada, Kenji Matsuo, Hoshi Himura, Tetsuro Nishimura, Ayako Kiritoshi, Sae Kawata, Masahiro Miyashita, Tomohiro Noda, Waki Imoto, Yasumitsu Mizobata, Hiroshi Kakeya, Kenichiro Uchida, K Yamamoto, Hiromasa Yamamoto, Ryo Deguchi, Shinichiro Kaga
Publikováno v:
Journal of Infection and Chemotherapy
CAPA (COVID-19 associated pulmonary aspergillosis) is an important complication of COVID-19. It has been reported that the incidence of CAPA is as high as 19%-33% worldwide. However, its onset has not been reported in Japan. A 72-year-old Japanese ma
Autor:
R. M. Brohet, R. E.P. Theunissen, K. Brinkman, A. J.J. Lammers, D.F. Postma, D. W. M. Verhagen, N. Bokhizzou, M. van den Berge, H. Visser, Anton S M Dofferhoff, G. Hermanides, Paul H. P. Groeneveld, Hannelore I. Bax, Robert-Jan Hassing, R. Rood, J. Ellerbroek, C. Koster, R. el Moussaoui
Publikováno v:
International Journal of Infectious Diseases, 101, 283-289. ELSEVIER SCI LTD
International Journal of Infectious Diseases, 101, 283-289
International Journal of Infectious Diseases
International Journal of Infectious Diseases, 101, pp. 283-289
International Journal of Infectious Diseases, 101, 283-289. Elsevier
International Journal of Infectious Diseases, Vol 101, Iss, Pp 283-289 (2020)
International Journal of Infectious Diseases, 101, 283-289
International Journal of Infectious Diseases
International Journal of Infectious Diseases, 101, pp. 283-289
International Journal of Infectious Diseases, 101, 283-289. Elsevier
International Journal of Infectious Diseases, Vol 101, Iss, Pp 283-289 (2020)
Highlights • After the global push for the use of Hydroxychloroquine and Chloroquine there is ongoing discussion about the effectivity of these drugs. • Findings of this observational study provide crucial data on a potential protective effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d60d6327be59a975b4c15b92cc8aec2d
https://research.rug.nl/en/publications/10552fdf-4813-485b-8375-4df66cb84728
https://research.rug.nl/en/publications/10552fdf-4813-485b-8375-4df66cb84728
Publikováno v:
Gastroenterology
Autor:
Lisa Olive, Eugene Athan, André F. Carvalho, Michael Maes, Michael Berk, Ken Walder, Adrienne O'Neil, Wolfgang Marx, Chiara C. Bortolasci, Gerwyn Morris, Basant K. Puri
Publikováno v:
Life Sciences
In this paper, a model is proposed of the pathophysiological processes of COVID-19 starting from the infection of human type II alveolar epithelial cells (pneumocytes) by SARS-CoV-2 and culminating in the development of ARDS. The innate immune respon
Autor:
Dana Burgdorf, Charles W. Goss, Elizabeth Ahrens, Cadence A. Kuklinski, Qinghua Lian, Kelly True, Mythili Srinivasan, Kenneth B. Schechtman, Matthew Haslam, Avraham Beigelman, Timothy J Casper, Sarah Bram, Gregory A. Storch, Carey-Ann D. Burnham, Huiqing Yin-Declue, Meghan A. Wallace, Jonathan S. Boomer, Jinli Wang, Mario Castro, Watcharoot Kanchongkittiphon, Leonard B. Bacharier, Andrea M. Coverstone, Yanjiao Zhou
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 22, Iss, Pp 100798-(2021)
Contemporary Clinical Trials Communications, Vol 22, Iss, Pp 100798-(2021)
Severe respiratory syncytial virus (RSV) bronchiolitis in early life is a significant risk factor for future recurrent wheeze (RW) and asthma. The goal of the Azithromycin to Prevent Wheezing following severe RSV bronchiolitis II (APW-RSV II) clinica
Autor:
Caroline Laprie, Caroline Solas, Jean-Sélim Driouich, Maxime Cochin, Paul-Rémi Petit, Gregory Moureau, Franck Touret, Xavier de Lamballerie, Antoine Nougairède
Publikováno v:
Antiviral Research
Drug repositioning has been used extensively since the beginning of the COVID-19 pandemic in an attempt to identify antiviral molecules for use in human therapeutics. Hydroxychloroquine and azithromycin have shown inhibitory activity against SARS-CoV
Autor:
Giovanna Capaldi Fortunato, Taís Maria Bauab, Karen Cristina dos Santos, Marlus Chorilli, Camila Fernanda Rodero, Luciani Gaspar de Toledo, Gabriel Davi Marena, Patrícia Bento da Silva, Matheus Aparecido dos Santos Ramos, Bruna Almeida Furquim de Camargo
Publikováno v:
International Journal of Pharmaceutics
Graphical abstract
Systemic infections is one of the major causes of mortality worldwide, and a shortage of drug approaches applied for the rapid and necessary treatment contribute to increase the levels of death in affected patients. Several dr
Systemic infections is one of the major causes of mortality worldwide, and a shortage of drug approaches applied for the rapid and necessary treatment contribute to increase the levels of death in affected patients. Several dr
Autor:
Srinivasan M; Division of Hospitalist Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Bacharier LB; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Goss CW; Division of Biostatistics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Zhou Y; Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA., Boomer J; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Bram S; Division of Hospitalist Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Burgdorf D; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Burnham CA; Department of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, CAB, USA., Casper T; Division of Hospitalist Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Castro M; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Coverstone A; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Haslam M; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Kanchongkittiphon W; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Kuklinski C; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Lian Q; Division of Biostatistics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Schechtman K; Division of Biostatistics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Storch GA; Division of Pediatric Infectious Disease, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., True K; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Wallace MA; Department of Pathology and Immunology, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, CAB, USA., Yin-DeClue H; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Ahrens E; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Wang J; Division of Biostatistics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA., Beigelman A; Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, 660 S. Euclid Ave, St. Louis, MO, 63110, USA.
Publikováno v:
Contemporary clinical trials communications [Contemp Clin Trials Commun] 2021 Jun 09; Vol. 22, pp. 100798. Date of Electronic Publication: 2021 Jun 09 (Print Publication: 2021).